Opinion: A dangerous loophole for drug ads needs to be closed
A loophole in prescription drug regulation exposes American consumers to false and misleading claims of drug ads via on-line businesses promoting potent drugs without accurate information about their risks and benefits.
Many countries prohibit direct-to-consumer advertising of prescription drugs. The United States allows it, but only if pharmaceutical companies comply with standards for accuracy and balance established and enforced by the Food and Drug Administration.
Read Original Article: Opinion: A dangerous loophole for drug ads needs to be closed »
